# Implementing HCV Treatment for High-risk Populations in Austin, Texas

> **NCT05460130** · NA · UNKNOWN · sponsor: **University of Texas at Austin** · enrollment: 64 (actual)

## Conditions studied

- Hepatitis C Virus Infection

## Interventions

- **BEHAVIORAL:** Simplified Hepatitis C Virus (HCV) Treatment Protocol

## Key facts

- **NCT ID:** NCT05460130
- **Lead sponsor:** University of Texas at Austin
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-09-29
- **Primary completion:** 2023-06
- **Final completion:** 2023-09-20
- **Target enrollment:** 64 (ACTUAL)
- **Last updated:** 2023-04-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05460130

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05460130, "Implementing HCV Treatment for High-risk Populations in Austin, Texas". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT05460130. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*